Japan Tissue Engineering Co (TSE:7774) Cash-to-Debt : No Debt ⁽¹⁾ (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Japan Tissue Engineering Co's cash to debt ratio for the quarter that ended in Sep. 2024 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Japan Tissue Engineering Co could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Japan Tissue Engineering Co's Cash-to-Debt or its related term are showing as below:

TSE:7774' s Cash-to-Debt Range Over the Past 10 Years
Min: 10.39 Med: No Debt Max: 31086.99
Current: No Debt

During the past 13 years, Japan Tissue Engineering Co's highest Cash to Debt Ratio was 31086.99. The lowest was 10.39. And the median was No Debt.

TSE:7774's Cash-to-Debt is ranked better than
99.87% of 1485 companies
in the Biotechnology industry
Industry Median: 7.49 vs TSE:7774: No Debt

Japan Tissue Engineering Co Cash-to-Debt Historical Data

The historical data trend for Japan Tissue Engineering Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Japan Tissue Engineering Co Cash-to-Debt Chart

Japan Tissue Engineering Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

1,888.01

3,032.11

5,270.64

31,086.99

No Debt

Japan Tissue Engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Japan Tissue Engineering Co's Cash-to-Debt

For the Biotechnology subindustry, Japan Tissue Engineering Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Japan Tissue Engineering Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Japan Tissue Engineering Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Japan Tissue Engineering Co's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Japan Tissue Engineering Co had no debt ⁽¹⁾.

Japan Tissue Engineering Co's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Japan Tissue Engineering Co had no debt ⁽¹⁾.

Japan Tissue Engineering Co (TSE:7774) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Japan Tissue Engineering Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Tissue Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022

Website

https://www.jpte.co.jp

Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines

Japan Tissue Engineering Co (TSE:7774) Cash-to-Debt : No Debt (1) (As of Sep. 2024)